
Joseph F. Murphy
Examiner (ID: 7917)
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1644, 1646 |
| Total Applications | 357 |
| Issued Applications | 157 |
| Pending Applications | 90 |
| Abandoned Applications | 110 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6750394
[patent_doc_number] => 20030044914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Methods employing XOR-6, a vitamin D-like receptor from xenopus'
[patent_app_type] => new
[patent_app_number] => 10/153827
[patent_app_country] => US
[patent_app_date] => 2002-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6075
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153827
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153827 | Methods employing XOR-6, a vitamin D-like receptor from xenopus | May 20, 2002 | Abandoned |
Array
(
[id] => 517186
[patent_doc_number] => 07189534
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'PRO4320 polynucleotide'
[patent_app_type] => utility
[patent_app_number] => 10/152395
[patent_app_country] => US
[patent_app_date] => 2002-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 550
[patent_figures_cnt] => 550
[patent_no_of_words] => 62938
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189534.pdf
[firstpage_image] =>[orig_patent_app_number] => 10152395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/152395 | PRO4320 polynucleotide | May 20, 2002 | Issued |
Array
(
[id] => 517178
[patent_doc_number] => 07189533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/145873
[patent_app_country] => US
[patent_app_date] => 2002-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 550
[patent_figures_cnt] => 550
[patent_no_of_words] => 63276
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10145873
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/145873 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 13, 2002 | Issued |
Array
(
[id] => 6751178
[patent_doc_number] => 20030045699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Membrane receptors for steroids and sterols'
[patent_app_type] => new
[patent_app_number] => 10/132382
[patent_app_country] => US
[patent_app_date] => 2002-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 4939
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045699.pdf
[firstpage_image] =>[orig_patent_app_number] => 10132382
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/132382 | Membrane receptors for steroids and sterols | Apr 25, 2002 | Abandoned |
Array
(
[id] => 6847726
[patent_doc_number] => 20030166893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Novel human nuclear transporters and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/132089
[patent_app_country] => US
[patent_app_date] => 2002-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9474
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166893.pdf
[firstpage_image] =>[orig_patent_app_number] => 10132089
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/132089 | Novel human nuclear transporters and polynucleotides encoding the same | Apr 23, 2002 | Abandoned |
Array
(
[id] => 729136
[patent_doc_number] => 07041795
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-09
[patent_title] => 'Potassium channel interacting polypeptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/118590
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 43958
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10118590
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/118590 | Potassium channel interacting polypeptides and uses thereof | Apr 7, 2002 | Issued |
Array
(
[id] => 723951
[patent_doc_number] => 07045308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => 'Modulators of leukocyte activation, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/112674
[patent_app_country] => US
[patent_app_date] => 2002-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 104
[patent_no_of_words] => 37698
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045308.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112674 | Modulators of leukocyte activation, compositions and methods of use | Mar 28, 2002 | Issued |
Array
(
[id] => 6869993
[patent_doc_number] => 20030082682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Polynucleotide and polypeptide sequence of RXR interacting protein, RB204'
[patent_app_type] => new
[patent_app_number] => 10/109324
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9398
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109324 | Polynucleotide and polypeptide sequence of RXR interacting protein, RB204 | Mar 27, 2002 | Abandoned |
Array
(
[id] => 1205158
[patent_doc_number] => 06716587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-06
[patent_title] => 'Antibodies to interleukin-4 receptors and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 10/104590
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 29
[patent_no_of_words] => 24767
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716587.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104590
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104590 | Antibodies to interleukin-4 receptors and uses thereof | Mar 21, 2002 | Issued |
Array
(
[id] => 6731008
[patent_doc_number] => 20030187198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Novel chemokine receptor obtained from a cDNA library of fetal liver-spleen'
[patent_app_type] => new
[patent_app_number] => 10/101148
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 48076
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20030187198.pdf
[firstpage_image] =>[orig_patent_app_number] => 10101148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/101148 | Chemokine receptor obtained from a CDNA library of fetal liver-spleen | Mar 18, 2002 | Issued |
Array
(
[id] => 716158
[patent_doc_number] => 07053121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'Compositions and methods for regulating circadian rhythms'
[patent_app_type] => utility
[patent_app_number] => 10/102430
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 7979
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/053/07053121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102430
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102430 | Compositions and methods for regulating circadian rhythms | Mar 18, 2002 | Issued |
Array
(
[id] => 7020374
[patent_doc_number] => 20050222393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'CHEMOKINE RECEPTOR OBTAINED FROM A CDNA LIBRARY OF FETAL LIVER-SPLEEN'
[patent_app_type] => utility
[patent_app_number] => 10/101673
[patent_app_country] => US
[patent_app_date] => 2002-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 47694
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10101673
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/101673 | Chemokine receptor obtained from a cDNA library of fetal liver-spleen | Mar 17, 2002 | Issued |
Array
(
[id] => 6745013
[patent_doc_number] => 20030022196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Methods and compositions for screening for altered cellular phenotypes'
[patent_app_type] => new
[patent_app_number] => 10/096339
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 46896
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 52
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096339
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096339 | Methods and compositions for screening for altered cellular phenotypes | Mar 7, 2002 | Issued |
Array
(
[id] => 6689053
[patent_doc_number] => 20030032778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'New member of the human syntaxin/epimorphin family'
[patent_app_type] => new
[patent_app_number] => 10/085188
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33752
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10085188
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/085188 | New member of the human syntaxin/epimorphin family | Feb 25, 2002 | Abandoned |
Array
(
[id] => 6696792
[patent_doc_number] => 20030108986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Compositions and methods comprising G-protein coupled receptors'
[patent_app_type] => new
[patent_app_number] => 10/079384
[patent_app_country] => US
[patent_app_date] => 2002-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 29231
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108986.pdf
[firstpage_image] =>[orig_patent_app_number] => 10079384
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/079384 | Compositions and methods comprising G-protein coupled receptors | Feb 19, 2002 | Abandoned |
| 10/030725 | High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors | Jan 30, 2002 | Abandoned |
| 10/048024 | Human nervous system-associated proteins | Jan 17, 2002 | Abandoned |
Array
(
[id] => 719509
[patent_doc_number] => 07049083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Methods for identifying modulators of N-type ion channel inactivation'
[patent_app_type] => utility
[patent_app_number] => 10/051843
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 13690
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049083.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051843 | Methods for identifying modulators of N-type ion channel inactivation | Jan 16, 2002 | Issued |
Array
(
[id] => 719533
[patent_doc_number] => 07049094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Methods for identifying modulators of N-type ion channel inactivation'
[patent_app_type] => utility
[patent_app_number] => 10/051841
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 14570
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051841 | Methods for identifying modulators of N-type ion channel inactivation | Jan 16, 2002 | Issued |
Array
(
[id] => 641646
[patent_doc_number] => 07122345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Nucleic acid encoding a NOVX13 polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/042865
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 123080
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042865 | Nucleic acid encoding a NOVX13 polypeptide | Jan 8, 2002 | Issued |